Safety Results Of A Phase 3 Study Of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil In Chemoradiotherapy For Locally Advanced Esophageal Carcinoma (Eso-Shanghai 1).
JOURNAL OF CLINICAL ONCOLOGY(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要